Mossberg Maria, Ståhl Anne-Lie, Kahn Robin, Kristoffersson Ann-Charlotte, Tati Ramesh, Heijl Caroline, Segelmark Mårten, Leeb-Lundberg L M Fredrik, Karpman Diana
Departments of Pediatrics and.
Nephrology, Clinical Sciences Lund, and.
J Am Soc Nephrol. 2017 Aug;28(8):2472-2481. doi: 10.1681/ASN.2016060637. Epub 2017 Mar 13.
The kinin system is activated during vasculitis and may contribute to chronic inflammation. C1-inhibitor is the main inhibitor of the kinin system. In this study, we investigated the presence of the kinin B1 receptor on endothelial microvesicles and its contribution to the inflammatory process. Compared with controls (=15), patients with acute vasculitis (=12) had markedly higher levels of circulating endothelial microvesicles, identified by flow cytometry analysis, and significantly more microvesicles that were positive for the kinin B1 receptor (<0.001). Compared with microvesicles from wild-type cells, B1 receptor-positive microvesicles derived from transfected human embryonic kidney cells induced a significant neutrophil chemotactic effect, and a B1 receptor antagonist blocked this effect. Likewise, patient plasma induced neutrophil chemotaxis, an effect decreased by reduction of microvesicle levels and by blocking the B1 receptor. We used a perfusion system to study the effect of patient plasma (=6) and control plasma (=6) on the release of microvesicles from glomerular endothelial cells. Patient samples induced the release of significantly more B1 receptor-positive endothelial microvesicles than control samples, an effect abrogated by reduction of the microvesicles in the perfused samples. Perfusion of C1-inhibitor-depleted plasma over glomerular endothelial cells promoted excessive release of B1 receptor-positive endothelial microvesicles compared with normal plasma, an effect significantly decreased by addition of C1-inhibitor or B1 receptor-antagonist. Thus, B1 receptor-positive endothelial microvesicles may contribute to chronic inflammation by inducing neutrophil chemotaxis, and the reduction of these microvesicles by C1-inhibitor should be explored as a potential treatment for neutrophil-induced inflammation.
激肽系统在血管炎期间被激活,可能导致慢性炎症。C1抑制剂是激肽系统的主要抑制剂。在本研究中,我们调查了内皮微泡上激肽B1受体的存在及其对炎症过程的作用。通过流式细胞术分析确定,与对照组(n = 15)相比,急性血管炎患者(n = 12)循环内皮微泡水平明显更高,且激肽B1受体阳性的微泡显著更多(P<0.001)。与来自野生型细胞的微泡相比,源自转染人胚肾细胞的B1受体阳性微泡诱导了显著的中性粒细胞趋化作用,且B1受体拮抗剂可阻断该作用。同样,患者血浆诱导中性粒细胞趋化,降低微泡水平和阻断B1受体可减弱该作用。我们使用灌注系统研究患者血浆(n = 6)和对照血浆(n = 6)对肾小球内皮细胞释放微泡的影响。患者样本诱导释放的B1受体阳性内皮微泡明显多于对照样本,灌注样本中微泡减少可消除该作用。与正常血浆相比,用C1抑制剂耗竭的血浆灌注肾小球内皮细胞可促进B1受体阳性内皮微泡的过度释放,添加C1抑制剂或B1受体拮抗剂可显著降低该作用。因此,B1受体阳性内皮微泡可能通过诱导中性粒细胞趋化导致慢性炎症,应探索用C1抑制剂减少这些微泡作为中性粒细胞诱导炎症的潜在治疗方法。